Jinyu Bio-technology Co., Ltd. (600201.SS)
CNY 7.14
(0.85%)
CNY 7.14
(0.85%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 414.83 Million | 344.65 Million | 533.08 Million | 699.61 Million | 405.24 Million | 422.46 Million |
| Net Income | 277.09 Million | 200.14 Million | 389 Million | 422.39 Million | 226.89 Million | 749.6 Million |
| Depreciation & Amortization | 189.25 Million | 200.16 Million | 191.58 Million | 173.64 Million | 107.09 Million | 96.8 Million |
| Deferred income taxes | -14.08 Million | 2.37 Million | -4.3 Million | 9.46 Million | 8.4 Million | -8.27 Million |
| Stock-based compensation | 57.22 Million | - | - | - | - | - |
| Change in working capital | -142.75 Million | -117.91 Million | -98.87 Million | 114.01 Million | 16.88 Million | -495.96 Million |
| Other non-cash items | -32.06 Million | 62.26 Million | 51.35 Million | -10.43 Million | 54.37 Million | 72.02 Million |
| Investing Cash Flow | -740.11 Million | 176.61 Million | -548.12 Million | -385.69 Million | 413.1 Million | -125.34 Million |
| Investments in PPE | -273.16 Million | -190.1 Million | -372.68 Million | -228.31 Million | -307.35 Million | -545.46 Million |
| Acquisitions | 17.15 Million | - | 544 Thousand | 39.79 Million | 590.95 Thousand | - |
| Investment purchases | -668.31 Million | -10.07 Million | -100 Thousand | -1.21 Billion | -53.6 Million | -20.4 Million |
| Sales/Maturities of investments | 24.19 Million | 55.88 Million | 42.49 Million | 45.22 Million | 39.77 Million | 40.93 Million |
| Other Investing Activities | -491.14 Million | 320.91 Million | -218.37 Million | 972.66 Million | 733.69 Million | 399.58 Million |
| Financing Cash Flow | 111.37 Million | -437.29 Million | -123.27 Million | 20.94 Million | -846.49 Million | -666.05 Million |
| Debt repayment | -10 Million | -60 Million | -504.73 Thousand | -40.08 Million | -12.5 Million | -160 Million |
| Dividends payments | -67.02 Million | -120.53 Million | -134.97 Million | -67.11 Million | -386.47 Million | -265.17 Million |
| Common Stock Repurchased | - | -366.13 Million | -1.66 Million | - | -505.52 Million | -129 Million |
| Common Stock Issuance | 185.03 Million | 306.13 Million | 2.16 Million | - | 505.52 Million | - |
| Other Financing Activities | 188.18 Million | -192.9 Million | 10.94 Million | 129.11 Million | -430.56 Million | -240.88 Million |
| Accounts receivables | -67.02 Million | -70.17 Million | -125.09 Million | -61.88 Million | 143.52 Million | -422.04 Million |
| Accounts payables | -70.17 Million | -29.58 Million | 4.66 Million | 278.57 Million | -162.4 Million | 27.72 Million |
| Inventory | 8.53 Million | -20.53 Million | 25.86 Million | -112.14 Million | 27.35 Million | -93.38 Million |
| Other working capital | -84.26 Million | 2.37 Million | -4.3 Million | 9.46 Million | 8.4 Million | -402.58 Million |
| Cash at beginning of period | 1.26 Billion | 1.18 Billion | 1.32 Billion | 986.43 Million | 1.01 Billion | 1.38 Billion |
| Cash at end of period | 1.05 Billion | 1.26 Billion | 1.18 Billion | 1.32 Billion | 986.43 Million | 1.01 Billion |
| Capital Expenditure | -273.16 Million | -190.1 Million | -372.68 Million | -228.31 Million | -307.35 Million | -545.46 Million |
| Effect of forex changes on cash | -246.92 | 99.05 Thousand | -84.02 Thousand | -303.8 Thousand | 64.98 Thousand | 206.44 Thousand |
| Net cash flow / Change in cash | -213.9 Million | 84.07 Million | -138.4 Million | 334.55 Million | -28.08 Million | -368.74 Million |
| Free Cash Flow | 141.66 Million | 154.54 Million | 160.4 Million | 471.29 Million | 97.88 Million | -123 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 46.62 Million | 17.33 Million | 105.58 Million | 277.09 Million | -4.67 Million | 153.88 Million |
| Depreciation & Amortization | - | 48.06 Million | 48.06 Million | 189.25 Million | 46.02 Million | -93.89 Million |
| Deferred income taxes | - | - | - | -14.08 Million | - | 1.25 Million |
| Stock-based compensation | - | - | - | 57.22 Million | 57.22 Million | -15.27 Million |
| Change in working capital | - | - | - | -142.75 Million | -58.49 Million | 100.99 Million |
| Other non-cash items | 33.92 Million | 143.48 Million | -59.34 Million | -32.06 Million | 183.51 Million | 7.84 Million |
| Investing Cash Flow | -22.14 Million | -314.51 Million | 38.99 Million | -740.11 Million | -502.87 Million | -223.46 Million |
| Investments in PPE | -19.65 Million | -10.91 Million | -33.55 Million | -273.16 Million | -118.36 Million | -84.71 Million |
| Acquisitions | 27.86 Thousand | 6115.73 | 760 Thousand | 17.15 Million | 5700.00 | 17.15 Million |
| Investment purchases | 588.31 Million | -592.31 Million | -456.8 Thousand | -668.31 Million | -668.31 Million | 30 Million |
| Sales/Maturities of investments | -322.19 Million | 27.71 Million | 551.51 Thousand | 24.19 Million | 13.43 Million | 6.92 Million |
| Other Investing Activities | -268.63 Million | -331.31 Million | 71.69 Million | -491.14 Million | -397.95 Million | -192.83 Million |
| Financing Cash Flow | -91.72 Million | -3.6 Million | -1.49 Million | 111.37 Million | -462.98 Thousand | 19.41 Million |
| Debt repayment | - | - | - | -10 Million | - | - |
| Dividends payments | -88.16 Million | - | - | -67.02 Million | -67.02 Million | - |
| Common Stock Repurchased | - | - | - | - | - | -185.03 Million |
| Common Stock Issuance | - | - | - | 185.03 Million | 185.03 Million | - |
| Other Financing Activities | -3.55 Million | -3.6 Million | -1.49 Million | 188.18 Million | -715.07 Thousand | 204.44 Million |
| Accounts receivables | - | - | - | -67.02 Million | -67.02 Million | 104.01 Million |
| Accounts payables | - | - | - | -70.17 Million | - | 15.27 Million |
| Inventory | - | - | - | 8.53 Million | 8.53 Million | -3.01 Million |
| Other working capital | - | - | - | - | - | -15.27 Million |
| Cash at beginning of period | 1.3 Billion | 1.13 Billion | 1.05 Billion | 1.26 Billion | 1.43 Billion | 1.48 Billion |
| Cash at end of period | 1.27 Billion | 902.86 Million | 1.13 Billion | 1.05 Billion | 1.05 Billion | 1.43 Billion |
| Capital Expenditure | -19.65 Million | -10.91 Million | -33.55 Million | -273.16 Million | -118.36 Million | -84.71 Million |
| Effect of forex changes on cash | - | -5607.07 | -5113.06 | -246.92 | -606.71 | 20.17 Thousand |
| Net cash flow / Change in cash | -27.79 Million | -233.08 Million | 83.18 Million | -213.9 Million | -383.96 Million | -49.22 Million |
| Free Cash Flow | 60.89 Million | 101.82 Million | 12.68 Million | 141.66 Million | 14.44 Million | 70.09 Million |
BRST
003100
IDM
SESHAPAPER
RWD
FFBC